Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Sirolimus for Cutaneous Microcystic Lymphatic Malformations
NCT03972592Phase 2Completed
- Sponsor
- University Hospital Tours
- Start
- Jun 2019
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in Lymphatic Malformation (LM), sponsored by University Hospital Tours. Started Jun 2019; status: completed.
02
Drugs
sirolimus
03
Conditions
Lymphatic Malformation (LM)
Beyond the preview
Go deeper on NCT03972592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03972592.